Quick Answer
Oncology Institute, Inc. reported Earnings Per Share Diluted of $0.54 (loss) per share for the year ending 2025.
- Oncology Institute, Inc. showed an increase of +23.9% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Oncology Institute, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Oncology Institute, Inc.'s Earnings Per Share Diluted has declined by 125.0%.
- Historical annual values: Fiscal year 2025: $0.54 (loss) per share | Fiscal year 2024: $0.71 (loss) per share | Fiscal year 2023: $0.92 (loss) per share | Fiscal year 2022: $0.21 (loss) per share | Fiscal year 2021: $0.16 (loss) per share | Fiscal year 2020: $0.24 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: